A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children
- PMID: 37592879
- DOI: 10.1080/09546634.2023.2241587
A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children
Abstract
Background: The efficacy and safety of an over-the-counter (OTC) 1% colloidal oatmeal cream versus a ceramide-based prescription barrier cream in children with mild-to-moderate atopic dermatitis (AD) were previously described.
Objectives: Here, findings are reported for the Black/African American subgroup.
Methods: Patients were randomized to 1% oatmeal cream or prescription barrier cream twice daily or as needed for three weeks. Assessments included Eczema Area and Severity Index (EASI) scores, Investigator's Global Atopic Dermatitis Assessment (IGADA) scores, and patients'/caregivers' assessment of eczema signs and symptoms.
Results: Overall, 49 Black/African American children aged 2-15 years with mild/moderate AD were included. At week 3, mean (SD) changes from baseline in EASI scores were -2.4 (1.7) with 1% oatmeal cream and -2.1 (2.3) with barrier cream; improvements were observed from week 1. At week 3, mean (SD) changes from baseline in IGADA scores were -0.6 (0.7) and -0.7 (0.6), respectively. Improvements in subjective ratings of signs/symptoms of eczema were observed. Both study treatments were well tolerated.
Conclusion: OTC 1% oatmeal cream was at least as effective and safe as prescription barrier cream in this population, providing a novel, fast-acting, and cost-effective option for the symptomatic treatment of mild-to-moderate AD in Black/African American children.
Keywords: African American; atopic dermatitis; black; children; colloidal oatmeal.
Similar articles
-
Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study.J Dermatolog Treat. 2017 Nov;28(7):659-667. doi: 10.1080/09546634.2017.1303569. Epub 2017 Apr 2. J Dermatolog Treat. 2017. PMID: 28366039 Clinical Trial.
-
A 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies.J Drugs Dermatol. 2017 Jul 1;16(7):671-676. J Drugs Dermatol. 2017. PMID: 28697218 Clinical Trial.
-
An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.J Drugs Dermatol. 2011 May;10(5):531-7. J Drugs Dermatol. 2011. PMID: 21533301 Clinical Trial.
-
Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.Hong Kong Med J. 2015 Oct;21(5):417-25. doi: 10.12809/hkmj144472. Epub 2015 Aug 28. Hong Kong Med J. 2015. PMID: 26314567 Review.
-
Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.Drugs. 2002;62(5):817-40. doi: 10.2165/00003495-200262050-00007. Drugs. 2002. PMID: 11929333 Review.
Cited by
-
Topical Treatments in Atopic Dermatitis: An Expansive Review.J Clin Med. 2024 Apr 10;13(8):2185. doi: 10.3390/jcm13082185. J Clin Med. 2024. PMID: 38673458 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
